doi:10.1093/ajcn/nqaa015 [53] Gatarek P, Kaluzna-Czaplinska J
The primary endpoint - MASH improvement absent fibrosis progression - was observed in 47%, 62%, and 43% of the 2.4, 4.8, and vs
27,49 Moreover, our study has some limitations that should be addressed
For logistic regression, ANN, and SVC, we applied the K-Nearest Neighbor (KNN) algorithm to fill in any missing values
Acid control does not imply symptom relief
It has long been prescribed for chronic liver disease , Alzheimers , and for patients recovering from chemotherapy